NITRIC OXIDE, PLP ACYLATION & THE PATHOPHYSIOLOGY OF MS

一氧化氮、PLP 酰化

• 批准号: 6330587
• 负责人: OSCAR A BIZZOZERO
• 金额: $ 14.26万
• 依托单位: UNIVERSITY OF NEW MEXICO
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 2003-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6330587
• 关键词: acyl coA; acyltransferase; adenosine triphosphate; catalyst; enzyme inhibitors; fatty acid biosynthesis; fatty acylation; laboratory rat; mass spectrometry; multiple sclerosis; myelin; myelin proteolipid; myelinopathy; nitric oxide; pathologic process; peroxynitrites; posttranslational modifications; protein structure; radionuclide double label

Our long-term goal is to understand the molecular mechanisms that control the formation and maintenance of CNS myelin and the factors that lead to its breakdown in multiple sclerosis (MS). Although the production of nitric oxide (NO) and peroxynitrite by activated macrophages and microglial cells is considered responsible for the destruction of myelin and oligodendrocytes in MS, the molecular targets of these agents in myelin have not yet been identified. We hypothesize that both the structure and fatty acid acylation of the abundant myelin proteolipid protein (PLP) are affected by NO and peroxynitrites, and that this may lead to myelin instability. Our specific aims are: 1- To characterize the mechanism of fatty acylation of PLP using endogenously generated 18/O-labeled fatty acids. This recently developed isotopomeric technique measures not only the acylation rate but also the minimal amount of proteins that are modified. Brain white matter slices from rapidly myelinating rats will be incubated with [3H]palmitate and H2/18/O, in the presence of a variety of metabolic poisons and enzyme inhibitors to ascertain whether PLP acylation (a) needs ATP, (b) requires the formation acyl-CoA, (c) using primarily fatty acids synthesized de novo, and (d) is catalyzed by a separate protein fatty acyltransferase. 2- To assess the effects of nitric oxide and peroxynitrite on the fatty acylation of PLP. We will determine the effects of pathological concentrations of endogenously-generated NO, exogenously-produced NO and peroxynitrite on acylation on PLP and lipids using tissue slices and the double-label technique described above. In addition, a variety of metabolic and structural studies will be carried out to identify the mechanism(s) by which nitrogen and oxygen free radicals could alter protein acylation. 3- To determine whether or not the structure and fatty acylation of the various PLP species isolated from MS brains are normal. The major PLP, DM-20 and 16 KdA proteolipid present in myelin and non-myelin membranes prepared from control and MS brains will be isolated and subjected to a comprehensive chemical and mass-spectrometric analysis. The studies proposed in this application will provide direct information into the mechanisms of myelin destruction that takes place in MS, and at the same time, they will aid our understanding of the biology of PLP and its only post-translational modification.

我们的长期目标是了解控制中枢神经系统髓磷脂形成和维持的分子机制，以及导致其在多发性硬化症（MS）中分解的因素。虽然被激活的巨噬细胞和小胶质细胞产生一氧化氮（NO）和过氧亚硝酸盐被认为是MS中髓磷脂和少突胶质细胞破坏的原因，但这些药物在髓磷脂中的分子靶点尚未确定。我们假设丰富的髓磷脂蛋白脂蛋白（PLP）的结构和脂肪酸酰化都受到NO和过氧亚硝酸盐的影响，这可能导致髓磷脂不稳定。我们的具体目标是：1-利用内源性18/ o标记脂肪酸表征PLP的脂肪酰化机制。这种最近发展起来的同位素技术不仅可以测量酰化速率，而且还可以测量被修饰的蛋白质的最小量。在多种代谢毒物和酶抑制剂存在的情况下，用[3H]棕榈酸盐和H2/18/O培养快速成髓鞘大鼠的脑白质切片，以确定PLP酰化(a)是否需要ATP， (b)是否需要形成酰基辅酶a， (c)是否主要使用从头合成的脂肪酸，以及(d)是否由单独的蛋白质脂肪酰基转移酶催化。2-评估一氧化氮和过氧亚硝酸盐对PLP脂肪酰化的影响。我们将使用组织切片和上述双标签技术确定内源性NO、外源性NO和过氧亚硝酸盐病理浓度对PLP和脂质酰化的影响。此外，将进行各种代谢和结构研究，以确定氮和氧自由基改变蛋白质酰化的机制。3-确定从MS脑中分离的各种PLP物种的结构和脂肪酰化是否正常。从对照和MS脑制备的髓磷脂和非髓磷脂膜中存在的主要PLP， DM-20和16 KdA蛋白脂将被分离并进行全面的化学和质谱分析。本申请中提出的研究将为MS中髓磷脂破坏的机制提供直接信息，同时，它们将有助于我们了解PLP的生物学及其唯一的翻译后修饰。